Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02681237 |
Title | A Study of Cediranib and Olaparib at Disease Worsening in Ovarian Cancer |
Recruitment | Completed |
Gender | female |
Phase | Phase I |
Variant Requirements | No |
Sponsors | University Health Network, Toronto |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | CAN |